Ulisse Biomed S.p.A. (UBM.MI)
EUR 0.78
(-2.26%)
EUR 0.78
(-2.26%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 66.2 Thousand | 138.43 Thousand | 276.62 Thousand | 429 Thousand | 11 Thousand | 76.00 |
| Cost of Revenue | 2.44 Million | 1.68 Million | 934.37 Thousand | 229 Thousand | 711 Thousand | 45.98 Thousand |
| Gross Profit | -2.37 Million | -1.54 Million | -657.75 Thousand | 200 Thousand | -700 Thousand | -45.9 Thousand |
| Operating Expenses | 1.91 Million | 156.08 Thousand | 80.6 Thousand | 80 Thousand | 417 Thousand | 1.81 Million |
| Selling, General and Administrative Expenses | 609.71 Thousand | -348.23 Thousand | -162.49 Thousand | -196.97 Thousand | 189.65 Thousand | 1.41 Million |
| Research and Development Expenses | 1.3 Million | 504.32 Thousand | 243.1 Thousand | 273.97 Thousand | - | - |
| Other Expenses | - | - | - | 80 Thousand | 417 Thousand | -401.16 Thousand |
| Cost and Expenses | 3.52 Million | 1.83 Million | 1.01 Million | 309 Thousand | 1.12 Million | 1.86 Million |
| Operating Income | -3.45 Million | -1.7 Million | -738.35 Thousand | 120 Thousand | -1.11 Million | -1.86 Million |
| Interest Expense | 139.00 | 164.00 | 206.00 | - | - | - |
| Income Tax Expense | - | 1.00 | - | 2000.00 | -18 Thousand | -2.00 |
| Earnings before Tax | -4.79 Million | -1.3 Million | -603.59 Thousand | 224 Thousand | -1.09 Million | -1.93 Million |
| Net Income | -4.79 Million | -1.3 Million | -603.59 Thousand | 222 Thousand | -1.08 Million | -1.93 Million |
| Earnings Per Share Basic | -0.22 | -0.16 | -0.07 | 0.03 | -0.15 | -0.27 |
| Earnings Per Share Diluted | -0.22 | -0.16 | -0.07 | 0.03 | -0.15 | -0.27 |
| Weighted Average Shares Outstanding | 21.56 Million | 8.06 Million | 8.06 Million | 7.25 Million | 7.25 Million | 7.25 Million |
| Weighted Average Shares Outstanding (Diluted) | 21.56 Million | 8.06 Million | 8.06 Million | 7.25 Million | 7.25 Million | 7.25 Million |
| Gross Margin | -35.89 | -11.16 | -2.38 | 0.47 | -63.64 | -604.03 |
| EBIT Margin | -32.36 | -9.97 | -1.77 | 0.40 | -96.45 | -23.9 Thousand |
| Profit Margin | -72.45 | -9.45 | -2.18 | 0.52 | -98.18 | -25.44 Thousand |
| EBITDA | -2.14 Million | -987.94 Thousand | -355.67 Thousand | 275.07 Thousand | -1.04 Million | -1.6 Million |
| Earnings Before Tax Margin | -52.25 | -12.28 | -2.67 | 0.28 | -101.45 | -24.5 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 185.42 Thousand | 185.42 Thousand | 25.03 Thousand | 66.2 Thousand | 25.03 Thousand | 16.13 Thousand |
| Cost of Revenue | 387.5 Thousand | 387.5 Thousand | 545.47 Thousand | 4.77 Million | 545.47 Thousand | 892.03 Thousand |
| Gross Profit | -202.08 Thousand | -202.08 Thousand | -520.43 Thousand | -4.7 Million | -520.43 Thousand | -875.89 Thousand |
| Operating Expenses | 623.14 Thousand | 623.14 Thousand | 817.33 Thousand | 291.01 Thousand | 1.42 Million | 91.81 Thousand |
| Selling, General and Administrative Expenses | 623.14 Thousand | 623.14 Thousand | 167.17 Thousand | - | 167.17 Thousand | 91.81 Thousand |
| Research and Development Expenses | - | - | 650.16 Thousand | - | 650.16 Thousand | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 1.01 Million | 1.01 Million | 1.36 Million | 5.06 Million | 1.97 Million | 983.84 Thousand |
| Operating Income | -825.22 Thousand | -825.22 Thousand | -1.33 Million | -4.99 Million | -1.97 Million | -967.71 Thousand |
| Interest Expense | - | - | - | 139.00 | - | 139.00 |
| Income Tax Expense | -764.39 Thousand | -764.39 Thousand | 5.00 | 2.48 Million | - | -2.00 |
| Earnings before Tax | -1.53 Million | -1.53 Million | -1.94 Million | -4.79 Million | -1.94 Million | -899.56 Thousand |
| Net Income | -1.53 Million | -1.53 Million | -1.94 Million | -4.79 Million | -1.94 Million | -899.56 Thousand |
| Earnings Per Share Basic | -0.07 | -0.07 | -0.09 | - | -0.09 | -0.11 |
| Earnings Per Share Diluted | -0.07 | -0.07 | -0.09 | - | -0.09 | -0.11 |
| Weighted Average Shares Outstanding | 21.8 Million | 21.8 Million | 21.56 Million | 21.56 Million | 21.56 Million | 8.06 Million |
| Weighted Average Shares Outstanding (Diluted) | 21.8 Million | 21.8 Million | 21.56 Million | 21.56 Million | 21.56 Million | 8.06 Million |
| Gross Margin | -1.09 | -1.09 | -20.79 | -71.05 | -20.79 | -54.27 |
| EBIT Margin | -6.63 | -6.63 | -77.26 | - | -77.63 | -50.12 |
| Profit Margin | -8.28 | -8.28 | -77.84 | -72.45 | -77.84 | -55.74 |
| EBITDA | -1.22 Million | -1.22 Million | -1.93 Million | - | -1.94 Million | -808.89 Thousand |
| Earnings Before Tax Margin | -4.45 | -4.45 | -53.44 | -75.44 | -78.87 | -59.96 |
SIRCA
SOLS
8886
7231
300407
CCLD